Barclays’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.43M | Buy |
38,981
+14,131
| +57% | +$1.61M | ﹤0.01% | 1711 |
|
|
2025
Q1 | $2.61M | Sell |
24,850
-15,122
| -38% | -$1.59M | ﹤0.01% | 1855 |
|
|
2024
Q4 | $4.28M | Sell |
39,972
-3,484
| -8% | -$373K | ﹤0.01% | 1706 |
|
|
2024
Q3 | $4.35M | Buy |
43,456
+7,247
| +20% | +$725K | ﹤0.01% | 1627 |
|
|
2024
Q2 | $3.05M | Buy |
36,209
+17,421
| +93% | +$1.47M | ﹤0.01% | 1434 |
|
|
2024
Q1 | $1.37M | Sell |
18,788
-14,997
| -44% | -$1.1M | ﹤0.01% | 2190 |
|
|
2023
Q4 | $2.41M | Buy |
33,785
+16,016
| +90% | +$1.14M | ﹤0.01% | 2032 |
|
|
2023
Q3 | $1.06M | Buy |
17,769
+3,366
| +23% | +$201K | ﹤0.01% | 2052 |
|
|
2023
Q2 | $1.04M | Sell |
14,403
-365
| -2% | -$26.3K | ﹤0.01% | 2128 |
|
|
2023
Q1 | $1.09M | Sell |
14,768
-22,555
| -60% | -$1.66M | ﹤0.01% | 2078 |
|
|
2022
Q4 | $2.49M | Sell |
37,323
-7,197
| -16% | -$481K | ﹤0.01% | 1503 |
|
|
2022
Q3 | $2.39M | Buy |
44,520
+35,502
| +394% | +$1.91M | ﹤0.01% | 1535 |
|
|
2022
Q2 | $502K | Sell |
9,018
-23,226
| -72% | -$1.29M | ﹤0.01% | 2558 |
|
|
2022
Q1 | $2.26M | Sell |
32,244
-58,893
| -65% | -$4.13M | ﹤0.01% | 1689 |
|
|
2021
Q4 | $8.78M | Buy |
91,137
+19,518
| +27% | +$1.88M | ﹤0.01% | 943 |
|
|
2021
Q3 | $6.22M | Buy |
71,619
+21,254
| +42% | +$1.85M | ﹤0.01% | 1129 |
|
|
2021
Q2 | $4.12M | Sell |
50,365
-14,154
| -22% | -$1.16M | ﹤0.01% | 1310 |
|
|
2021
Q1 | $6.14M | Buy |
64,519
+18,415
| +40% | +$1.75M | ﹤0.01% | 1056 |
|
|
2020
Q4 | $2.86M | Sell |
46,104
-29,806
| -39% | -$1.85M | ﹤0.01% | 1358 |
|
|
2020
Q3 | $4.51M | Sell |
75,910
-36,771
| -33% | -$2.19M | ﹤0.01% | 1021 |
|
|
2020
Q2 | $7.86M | Sell |
112,681
-16
| -0% | -$1.12K | 0.01% | 745 |
|
|
2020
Q1 | $5.11M | Sell |
112,697
-33,689
| -23% | -$1.53M | ﹤0.01% | 861 |
|
|
2019
Q4 | $9.52M | Buy |
146,386
+24,760
| +20% | +$1.61M | 0.01% | 872 |
|
|
2019
Q3 | $7.55M | Sell |
121,626
-27,326
| -18% | -$1.7M | ﹤0.01% | 898 |
|
|
2019
Q2 | $10.6M | Buy |
148,952
+14,486
| +11% | +$1.03M | 0.01% | 812 |
|
|
2019
Q1 | $10.5M | Buy |
134,466
+26,167
| +24% | +$2.05M | 0.01% | 742 |
|
|
2018
Q4 | $9.17M | Sell |
108,299
-123,490
| -53% | -$10.5M | 0.01% | 742 |
|
|
2018
Q3 | $39.7M | Sell |
231,789
-7,877
| -3% | -$1.35M | 0.03% | 341 |
|
|
2018
Q2 | $31M | Buy |
239,666
+199,136
| +491% | +$25.7M | 0.03% | 364 |
|
|
2018
Q1 | $4.18M | Buy |
40,530
+33,647
| +489% | +$3.47M | ﹤0.01% | 995 |
|
|
2017
Q4 | $588K | Buy |
6,883
+5,620
| +445% | +$480K | ﹤0.01% | 1958 |
|
|
2017
Q3 | $108K | Sell |
1,263
-6,314
| -83% | -$540K | ﹤0.01% | 2673 |
|
|
2017
Q2 | $574K | Sell |
7,577
-35,326
| -82% | -$2.68M | ﹤0.01% | 1842 |
|
|
2017
Q1 | $2.83M | Buy |
42,903
+1,658
| +4% | +$109K | ﹤0.01% | 1015 |
|
|
2016
Q4 | $2.61M | Buy |
41,245
+591
| +1% | +$37.5K | ﹤0.01% | 1030 |
|
|
2016
Q3 | $2.59M | Buy |
40,654
+40,016
| +6,272% | +$2.55M | ﹤0.01% | 953 |
|
|
2016
Q2 | $47K | Sell |
638
-13,901
| -96% | -$1.02M | ﹤0.01% | 2593 |
|
|
2016
Q1 | $971K | Buy |
14,539
+12,764
| +719% | +$852K | ﹤0.01% | 1411 |
|
|
2015
Q4 | $119K | Sell |
1,775
-7,795
| -81% | -$523K | ﹤0.01% | 2240 |
|
|
2015
Q3 | $507K | Buy |
9,570
+8,110
| +555% | +$430K | ﹤0.01% | 1717 |
|
|
2015
Q2 | $91K | Sell |
1,460
-4,405
| -75% | -$275K | ﹤0.01% | 2396 |
|
|
2015
Q1 | $280K | Buy |
5,865
+2,481
| +73% | +$118K | ﹤0.01% | 2151 |
|
|
2014
Q4 | $113K | Sell |
3,384
-2,722
| -45% | -$90.9K | ﹤0.01% | 2639 |
|
|
2014
Q3 | $175K | Buy |
6,106
+536
| +10% | +$15.4K | ﹤0.01% | 2372 |
|
|
2014
Q2 | $215K | Buy |
5,570
+508
| +10% | +$19.6K | ﹤0.01% | 2355 |
|
|
2014
Q1 | $211K | Buy |
5,062
+2,044
| +68% | +$85.2K | ﹤0.01% | 2358 |
|
|
2013
Q4 | $98K | Sell |
3,018
-20,761
| -87% | -$674K | ﹤0.01% | 3041 |
|
|
2013
Q3 | $638K | Buy |
23,779
+20,004
| +530% | +$537K | ﹤0.01% | 1974 |
|
|
2013
Q2 | $88K | Buy |
+3,775
| New | +$88K | ﹤0.01% | 3091 |
|